产品介绍
猫白血病是猫常见的非创伤性致死疾病，是由猫白血病病毒和猫肉瘤病毒引起的恶性肿瘤性传染病。主要特征是恶性淋巴肿瘤、骨髓性白血病以及变性性胸腺萎缩和非再生性贫血等，其中对猫最严重的是恶性淋巴肿瘤。幼猫易感性高，随年龄增长易感性降低。
|
产品名称
|
类型
|
货号
|
来源
|
建议使用
|
应用
|
|
FLV66
|
rAg
|
|
E.coli
|
包被/标记
|
EIA、LF
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| VHH-mFc Isotype Control Antibody, PerCP|VHH-mFc同型对照抗体，PerCP(靶标：纳米抗体-小鼠Fc融合同型对照) |
380 |
| VHH-hFc (IgG1) Isotype Control Antibody, PerCP|VHH-hFc（IgG1）同型对照抗体，PerCP(靶标：纳米抗体-人IgG1 Fc融合同型对照) |
159 |
| Anti-Human CDH19/Cadherin-19 Recombinant Antibody , PerCP|抗人CDH19/Cadherin-19重组抗体，PerCP(靶标：人钙黏蛋白19) |
313 |
| Anti-sLea/CA19-9 Recombinant Antibody, PerCP|抗sLea/CA19-9重组抗体，PerCP(靶标：癌抗原19-9（唾液酸化Lewis A）) |
169 |
| Anti-sLea/CA19-9 Recombinant Antibody, PerCP|抗sLea/CA19-9重组抗体，PerCP(靶标：癌抗原19-9（唾液酸化Lewis A）) |
178 |
| Anti-Human ENTPD2/CD39L1 Recombinant Antibody , PerCP|抗人ENTPD2/CD39L1重组抗体，PerCP(靶标：人外核苷三磷酸二磷酸水解酶2) |
242 |
| Anti-Mouse ENTPD2/CD39L1 Recombinant Antibody , PerCP|抗小鼠ENTPD2/CD39L1重组抗体，PerCP(靶标：小鼠外核苷三磷酸二磷酸水解酶2) |
189 |
| Anti-Human P2RX4 Recombinant Antibody , PerCP|抗人P2RX4重组抗体，PerCP(靶标：人P2X嘌呤受体4) |
467 |
| Anti-Human TMEFF1 Recombinant Antibody, PerCP|抗人TMEFF1重组抗体，PerCP(靶标：人跨膜蛋白含EGF样和卵泡抑素样结构域1) |
529 |
| Anti-Human HS6ST2 Recombinant Antibody , PerCP|抗人HS6ST2重组抗体，PerCP(靶标：人硫酸乙酰肝素6-O-磺基转移酶2) |
236 |
| Anti-Human HS6ST2 Recombinant Antibody , PerCP|抗人HS6ST2重组抗体，PerCP(靶标：人硫酸乙酰肝素6-O-磺基转移酶2) |
308 |
| Anti-Mouse TER-119/Erythroid Cells Recombinant Antibody, PerCP|抗小鼠TER-119/红细胞重组抗体，PerCP(靶标：小鼠红细胞抗原TER-119) |
322 |
| Anti-Human GPC2/Glypican-2 Recombinant Antibody , PerCP|抗人GPC2/Glypican-2重组抗体，PerCP(靶标：人磷脂酰肌醇蛋白聚糖2) |
189 |
| Anti-Human GPC2/Glypican-2 Recombinant Antibody, PerCP|抗人GPC2/Glypican-2重组抗体，PerCP(靶标：人磷脂酰肌醇蛋白聚糖2) |
220 |
| Anti-Human LAMP5 Recombinant Antibody, PerCP|抗人LAMP5重组抗体，PerCP(靶标：人溶酶体相关膜蛋白5) |
425 |
| Anti-Human CADM3/NECL-1/TSLL1 Recombinant Antibody , PerCP|抗人CADM3/NECL-1/TSLL1重组抗体，PerCP(靶标：人细胞黏附分子3) |
193 |
| Anti-Human HLA-A, B, C Recombinant Antibody, PerCP|抗人HLA-A、B、C重组抗体，PerCP(靶标：人MHC I类HLA-A/B/C) |
336 |
| Anti-Human HLA-B*27 Recombinant Antibody, PerCP|抗人HLA-B*27重组抗体，PerCP(靶标：人HLA-B*27) |
200 |
| Anti-Human HLA-DRA Recombinant Antibody, PerCP|抗人HLA-DRA重组抗体，PerCP(靶标：人MHC II类HLA-DRA) |
245 |
| Anti-Human HLA-DRB1 Recombinant Antibody, PerCP|抗人HLA-DRB1重组抗体，PerCP(靶标：人MHC II类HLA-DRB1) |
127 |
